Breaking News Instant updates and real-time market news.

ALXN

Alexion

$116.97

2.32 (2.02%)

09:35
01/22/19
01/22
09:35
01/22/19
09:35

European Patent Office revokes Alexion patent for Soliris

The European Patent Office revoked a patent held by Alexion related to Soliris "because at least one ground for opposition prejudices the maintenance of the European patent," according to a decision of an oral proceeding posted to the EPO site. Reference Link

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

ALXN Alexion
$116.97

2.32 (2.02%)

01/22/19
FBCO
01/22/19
NO CHANGE
Target $156
FBCO
Outperform
Credit Suisse sees limited fundamental impact to Alexion from EU IP setback
Credit Suisse analyst Martin Auster notes that Alexion indicated that the European Patent Office has revoked the new Soliris formulation patent previously granted, following an opposition from potential competitors. The company expects to receive the written decision over the next few weeks, when it will likely appeal the outcome, a process that could take 3-5 years, Auster notes. The analyst believes investors currently assign limited protective value from this formulation patent, with no change to his thesis from a fundamental perspective. He reiterates an Outperform rating and $156 price target on the shares.
01/03/19
PIPR
01/03/19
NO CHANGE
PIPR
Piper sees Alexion, Biogen as potential targets after Celgene buyout
Piper Jaffray analyst Christopher Raymond remains "bullish on biotech" in the wake the announced acquisition of Celgene (CELG) by Bristol-Myers Squibb (BMY) for $74B in cash and stock, representing a 54% premium from yesterday's close. In a research note titled "Bristol for CELG - In Retrospect, it Makes Perfect Sense," Raymond says the market is likely to ask "who's next?" Among large-caps, Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) would seem to make sense as potential targets, as well as BioMarin (BMRN), Raymond writes. And while any smid cap could likely be seen as a take-out candidate, Aimmune Therapeutics (AIMT), Deciphera Pharmaceuticals (DCPH) and Rigel Pharmaceuticals (RIGL) "in particular could make sense to any strategic buyer," adds the analyst.
12/24/18
STFL
12/24/18
NO CHANGE
STFL
Hold
Alexion consensus will need to come down due to Ultimoris pricing, says Stifel
Stifel analyst Paul Matteis said Alexion's U.S. pricing for Ultomiris is below what he had modeled and it does not appear to him that sell-side numbers align with the company's conservative pricing strategy, leading him to tell investors that "Street numbers will need to come down to incorporate a new reality." However, he also sees "two major positives" from the pricing decision: namely that it should provide a "huge" tailwind for Soliris-to-Ultomiris conversions and that the company should earn "valuable brand equity" with payors. Matteis keeps a Hold rating on Alexion shares.
12/21/18
PIPR
12/21/18
NO CHANGE
Target $177
PIPR
Overweight
Piper says Alexion early approval should help continue complement 'dominance'
Piper Jaffray analyst Christopher Raymond notes that expectations were for Ultomiris to be approved in February, meaning today's decision came roughly two months early, which will pull forward the timeline for Alexion's market conversion from Soliris to Ultomiris. The earlier than expected approval, along with the "high bar Ultomiris has set," positions Alexion to "continue its dominance in the complement space," said Raymond. He maintains an Overweight rating and $177 price target on Alexion shares.

TODAY'S FREE FLY STORIES

RHHBY

Roche

$0.00

(0.00%)

05:16
03/19/19
03/19
05:16
03/19/19
05:16
Hot Stocks
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

05:10
03/19/19
03/19
05:10
03/19/19
05:10
General news
FX Action: USD-CAD has remained steady-but-heavy »

FX Action: USD-CAD has…

ALGN

Align Technology

$253.83

1.51 (0.60%)

05:09
03/19/19
03/19
05:09
03/19/19
05:09
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGMB

MGM Holdings

$0.00

(0.00%)

, MGM.B

MGM Holdings

$0.00

(0.00%)

05:03
03/19/19
03/19
05:03
03/19/19
05:03
Recommendations
MGM Holdings, MGM Holdings analyst commentary at Imperial Capital »

MGM Holdings price target…

MGMB

MGM Holdings

$0.00

(0.00%)

MGM.B

MGM Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$13.45

-0.07 (-0.52%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Downgrade
Camping World rating change  »

Camping World downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst Lowe…

AHT

Ashford Hospitality

$4.81

0.09 (1.91%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ANDE

Andersons

$34.32

-0.26 (-0.75%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Andersons management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 07

    May

04:55
03/19/19
03/19
04:55
03/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

CPST

Capstone Turbine

$0.93

0.0602 (6.91%)

, CEVA

Ceva

$27.85

-0.63 (-2.21%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Roth Capital to hold a conference »

31st Annual ROTH…

CPST

Capstone Turbine

$0.93

0.0602 (6.91%)

CEVA

Ceva

$27.85

-0.63 (-2.21%)

ORA

Ormat Technologies

$55.25

-0.12 (-0.22%)

ATEA

Astea

$0.00

(0.00%)

AKTS

Akoustis

$6.47

-0.02 (-0.31%)

ALRM

Alarm.com

$61.72

0.74 (1.21%)

VERI

Veritone

$6.49

0.23 (3.67%)

WAAS

AquaVenture

$19.78

-0.6 (-2.94%)

SRAX

Social Reality

$2.65

-0.06 (-2.21%)

MOBL

MobileIron

$5.03

0.03 (0.60%)

RUN

Sunrun

$14.85

0.09 (0.61%)

QTNA

Quantenna Communications

$21.07

-0.21 (-0.99%)

CWCO

Consolidated Water

$13.49

0.09 (0.67%)

EVER

EverQuote

$7.50

0.18 (2.46%)

PXLW

Pixelworks

$4.12

0.33 (8.71%)

BBSI

Barrett Business

$79.51

0.04 (0.05%)

FIVN

Five9

$54.86

0.43 (0.79%)

TMDI

Titan Medical

$3.29

(0.00%)

MNLO

Menlo Therapeutics

$7.98

0.15 (1.92%)

CRWS

Crown Crafts

$5.22

-0.025 (-0.48%)

ASUR

Asure Software

$6.22

-0.03 (-0.48%)

BOXL

Boxlight

$2.85

0.09 (3.26%)

CTEK

CynergisTek

$4.55

0.11 (2.48%)

EIDX

Eidos Therapeutics

$20.22

0.54 (2.74%)

IOTS

Adesto Technologies

$6.33

-0.1 (-1.56%)

SUMR

Summer Infant

$0.75

0.0024 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 25

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    Mar

  • 28

    Mar

  • 28

    Mar

  • 21

    May

  • 28

    May

  • 11

    Jun

NOAH

Noah Holdings

$46.87

0.5 (1.08%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Noah Holdings management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

ALDR

Alder Biopharmaceuticals

$13.72

0.21 (1.55%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Alder Biopharmaceuticals management to meet with SVB Leerink »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

JMP

JMP Group

$3.86

-0.085 (-2.15%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WCN

Waste Connections

$84.90

0.48 (0.57%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Waste Connections management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 17

    May

WIFI

Boingo Wireless

$21.14

-0.65 (-2.98%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Boingo Wireless management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

  • 28

    May

MKTX

MarketAxess

$237.77

4.27 (1.83%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
MarketAxess management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGA

Magna

$49.29

0.45 (0.92%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Magna management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 21

    Mar

CYAD

Celyad

$21.35

(0.00%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Celyad management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 09

    Apr

AEE

Ameren

$72.49

-0.55 (-0.75%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ameren management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NGVT

Ingevity

$106.91

5.72 (5.65%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ingevity management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 25

    Apr

04:55
03/19/19
03/19
04:55
03/19/19
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

ITCI

Intra-Cellular

$12.84

-0.59 (-4.39%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Intra-Cellular participates in a conference call with JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Sep

PLYA

Playa Hotels & Resorts

$8.07

0.12 (1.51%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Playa Hotels & Resorts management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

EXTN

Exterran

$18.30

0.4 (2.23%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Exterran management to meet with Piper Jaffray »

Meetings to be held In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 25

    Apr

ITRM

Iterum Therapeutics

$5.63

0.16 (2.93%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Iterum Therapeutics management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.